Myeloid-specific estrogen receptor α deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development

Vicent Ribas, Brian G. Drew, Jamie A. Le, Teo Soleymani, Pedram Daraei, Daniel Sitz, Laila Mohammad, Darren C. Henstridge, Mark A. Febbraio, Sylvia Curtis Hewitt, Kenneth S Korach, Steven J. Bensinger, Andrea L Hevener

Research output: Contribution to journalArticleResearchpeer-review

127 Citations (Scopus)


ERα is expressed in macrophages and other immune cells known to exert dramatic effects on glucose homeostasis.We investigated the impact of ERα expression on macrophage function to determine whether hematopoietic or myeloid-specific ERα deletion manifests obesity-induced insulin resistance in mice. Indeed, altered plasma adipokine and cytokine levels, glucose intolerance, insulin resistance, and increased adipose tissue mass were observed in animals harboring a hematopoietic or myeloid-specific deletion of ERα. A similar obese phenotype and increased atherosclerotic lesion area was displayed in LDL receptor-KO mice transplanted with ERα -/-bone marrow. In isolated macrophages, ERα was necessary for repression of inflammation, maintenance of oxidative metabolism, IL-4-mediated induction of alternative activation, full phagocytic capacity in response to LPS, and oxidized LDL-induced expression of ApoE and Abca1. Furthermore, we identified ERα as a direct regulator of macrophage transglutaminase 2 expression, a multifunctional atheroprotective enzyme. Our findings suggest that diminished ERαexpression in hematopoietic/myeloid cells promotes aspects of the metabolic syndrome and accelerates atherosclerosis in female mice.

Original languageEnglish
Pages (from-to)16457-16462
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Issue number39
Publication statusPublished - 27 Sep 2011
Externally publishedYes


  • Estrogen action
  • Insulin sensitivity

Cite this